Blood markers may guide septic shock treatment in new pilot study
NCT ID NCT05824767
First seen Feb 05, 2026 · Last updated May 08, 2026 · Updated 15 times
Summary
This study looked at 40 adults with septic shock to see if two blood markers, renin and DPP3, can predict who will respond better to a drug called angiotensin II compared to standard blood pressure-raising medicines. The goal was to gather knowledge for future treatment decisions, not to cure or control the disease. Participants were already in intensive care and needed strong medications to keep their blood pressure up.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SEPTIC SHOCK are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University of New Mexico Health Sciences Center
Albuquerque, New Mexico, 87106, United States
Conditions
Explore the condition pages connected to this study.